Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice.
about
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderReview of pharmacological treatment in mood disorders and future directions for drug development.Cell atrophy and loss in depression: reversal by antidepressant treatmentRegulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disordersAllosteric Modulation of Sigma-1 Receptors Elicits Rapid Antidepressant ActivityMolecular actions and clinical pharmacogenetics of lithium therapyFGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizersGSK-3: Functional Insights from Cell Biology and Animal Models.Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stressHippocampal and thalamic neuronal metabolism in a putative rat model of schizophrenia.A new avenue for lithium: intervention in traumatic brain injury.GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersNeuroprotective action of lithium in disorders of the central nervous system.Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury.Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms.GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation.Wnt and lithium: a common destiny in the therapy of nervous system pathologies?PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications.Caspase-3 and GFAP as early markers for apoptosis and astrogliosis in shRNA-induced hippocampal cytotoxicity.Dentate gyrus-CA3 glutamate release/NMDA transmission mediates behavioral despair and antidepressant-like responses to leptin.Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation.Hippocampal GSK3β as a Molecular Link Between Obesity and Depression.
P2860
Q24626017-9B82CF23-B15D-4FE9-A294-95E13413B0BAQ26853509-4D744A52-51BB-4694-A413-4E4CAE4F27B5Q27013609-DF6FCC0B-030C-4C3A-B233-92C39F097B9DQ27027115-13CE8671-3CB9-4DCE-947F-48FD9CF424F8Q28273055-E92C86DA-1FDF-4D20-A944-4C34F4468118Q28307770-FD730AA6-91D2-4EE5-9714-9ABD6399EC07Q28570740-9BFAD1F7-D787-48F4-A4E8-A22C0B420313Q30472813-48EA37C3-AAFB-4B93-9DC6-7998B5FF2E4CQ30474415-D934FA0D-1E87-430A-A965-1D405F55D7BAQ30651146-C4172FA0-52B2-4384-A8DB-4DE243D7C942Q30849611-92C9BCCE-7D36-47AC-A646-65C447D05E65Q33777980-B9289458-8EB6-4BB8-AC3A-DDFB954217B1Q35154467-A6126792-3542-49A1-9C12-53BBC9816AFFQ35197096-70E41F93-6EA9-4C0C-AC51-DFB9072F0045Q35212429-2195042F-2399-4996-B51A-534062CE365FQ35356604-99F7E4E9-02FD-453C-9BD7-2256CFC53644Q35682342-D9C0E24E-0EC1-4382-9B22-73D4C36AD982Q35844079-6EB3EF41-8821-42D1-9200-23A32110889EQ36649760-99689188-5646-4318-8C8F-5E10FDF33A06Q38113139-00435BEF-E76A-46B7-8F25-DF02E88E123AQ38776236-27AD797C-D6FB-4788-A017-435886912FF6Q38890067-161E2D4F-ECBB-4C56-AB09-94F56CF1264BQ40342529-4230E328-212F-42D3-A0A4-E4C6A676F7B0Q42268463-6A14D84E-2DD4-491C-BF09-51688D9EDA9BQ47731890-AAADB28E-DAD9-41A4-9931-3409A42563BFQ48223579-CDE54D74-E501-415C-8544-DAB0B376461F
P2860
Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lentivirally mediated GSK-3β s ...... like effects in stressed mice.
@ast
Lentivirally mediated GSK-3β s ...... like effects in stressed mice.
@en
type
label
Lentivirally mediated GSK-3β s ...... like effects in stressed mice.
@ast
Lentivirally mediated GSK-3β s ...... like effects in stressed mice.
@en
prefLabel
Lentivirally mediated GSK-3β s ...... like effects in stressed mice.
@ast
Lentivirally mediated GSK-3β s ...... like effects in stressed mice.
@en
P2093
P2860
P1476
Lentivirally mediated GSK-3β s ...... like effects in stressed mice.
@en
P2093
Chi-Tso Chiu
De-Maw Chuang
Joshua G Hunsberger
Naoto Omata
Pablo R Moya
Peter Leeds
Zhifei Wang
P2860
P304
P356
10.1017/S1461145710000726
P577
2010-07-07T00:00:00Z